Statement: There were no cases of Cellulitis, Vertigo or Anaemia in the primary trial.
Primary_evidence: Adverse Events 1:   Total: 8/101 (7.92%)   Vertigo * 1/101 (0.99%)   Infected lymphocele * 1/101 (0.99%)   Ejection fraction decreased * 5/101 (4.95%)   Lymphoedema * 1/101 (0.99%)